News

Northern Venture Announces Equity Allotment and Voting Rights

Northern Venture Announces Equity Allotment and Voting Rights

Northern Venture Trust PLC Equity Allotment Announcement

Northern Venture Trust PLC (“the Company”) has announced the allotment of 908,739 ordinary shares, each with a nominal value of 25p, to shareholders who participated in the Dividend Investment Scheme. The subscription price for these shares was established at 57.9p each. With this latest allotment, the total number of ordinary shares issued by the Company has reached 200,907,847.

Admission of New Shares

The Company is working to ensure that the newly allotted ordinary shares are admitted to the Official List of the Financial Conduct Authority (“the FCA”) as soon as possible. Additionally, these shares will be made available for trading on the London Stock Exchange's market for listed securities. Trading is expected to begin around the end of this month.

Total Capital and Voting Rights

In accordance with the FCA’s Disclosure Guidance and Transparency Rules (the “DTRs”), the Company has informed the market that its capital consists of 200,907,847 ordinary shares, each valued at 25p. It is important to note that all ordinary shares carry voting rights, and the Company does not hold any treasury shares. Therefore, the total number of voting rights available in the Company is also 200,907,847 (“the Figure”). This number serves as a reference for shareholders and others to determine if they need to report any changes in their voting rights regarding the Company's shares, as required by the DTRs.

Enquiries and Further Information

For any questions related to this announcement, shareholders are encouraged to contact Sarah Williams or James Sly at Mercia Fund Management Limited by calling 0330 223 1430. The Company is dedicated to keeping its stakeholders informed about important developments.

Frequently Asked Questions

What does the recent allotment of shares signify?

The allotment signifies that Northern Venture Trust PLC has given shareholders the chance to enhance their investment through the Dividend Investment Scheme.

When will the new shares begin trading?

Trading for the newly allotted shares is anticipated to start on or around the end of this month.

What are the total voting rights for ordinary shares?

The total voting rights for the ordinary shares stand at 200,907,847, according to the latest disclosures.

How is the subscription price for new shares determined?

The subscription price is set based on the Company's established pricing mechanisms, reflecting current market conditions and shareholder interest.

Who can shareholders contact for queries regarding the share allotment?

Shareholders can contact Sarah Williams or James Sly at Mercia Fund Management Limited for any inquiries related to this announcement.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Discover Caron Scientific's Innovative 7406 Incubator Shaker

Updated Category News Views 314

Introducing the 7406 Incubator Shaker by Caron Scientific Caron Scientific, Inc. has raised the bar in environmental testing and laboratory equipment with the launch of their newest innovation: the 7406 Incubator Shaker. Known for its dedication to providing state-of-the-art incubation solutions, Caron Scientific presented this remarkable product at a prominent...

Continue Reading
Markets Steady as Analysts Predict Seasonal Trends Amidst Fluctuations

Updated Category News Views 409

US Stocks Look to Rebound Following Recent Sell-Off U.S. stock futures showed an upward trend recently, bouncing back from a notable sell-off. Most benchmark indices are witnessing gains in premarket trading while the small-cap Russell 2000 remains slightly down. Nvidia's Effects on Technology Sector Nvidia Corp. (NASDAQ: NVDA) experienced a significant decline of over 8%...

Continue Reading
Class Action Update for Avantor, Inc. Investors: Key Info Here

Updated Category News Views 159

Understanding the Avantor, Inc. Class Action Lawsuit Avantor, Inc. (NYSE: AVTR) is a prominent provider of scientific products and services designed to cater to various sectors including biotechnology and pharmaceuticals. This article sheds light on the ongoing class action lawsuit initiated on behalf of investors who acquired shares of Avantor during a specified class...

Continue Reading
Hyphens Pharma Partners with Louis Widmer to Launch Cerapro® MED

Updated Category News Views 118

Hyphens Pharma Collaborates with Louis Widmer for Cerapro® MED Hyphens Pharma International Limited is thrilled to announce a significant partnership with Louis Widmer SA for the commercialization of their innovative product, Cerapro® MED Skin Barrier Cream. This agreement enables Louis Widmer to promote and distribute Cerapro® MED in six European countries. About...

Continue Reading
Tarsus Pharmaceuticals Engages Investors at Key Conference

Updated Category News Views 140

Engagement in a Notable Investor Conference Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) has exciting news for its stakeholders! The company recently declared its participation in an essential fireside chat at the Guggenheim 2nd Annual Healthcare Innovation Conference. This event is set to take place in Boston and will commence at 11:30 a.m. PT / 2:30 p.m. ET on a Tuesday...

Continue Reading